menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Moderna CEO Stéphane Bancel Gets Pay Bump Despite Revenue Drop

    FIERCE PHARMA

    Pfizer Wins Patent Office Ruling Canceling Moderna COVID Patents

    REUTERS

    Genevant, Arbutus File Global Patent Cases Against Moderna

    GLOBENEWSWIRE

    Moderna Gets UK MHRA Approval For RSV Vaccine

    ACCESSWIRE

    Moderna to Present at Upcoming Conferences in March 2025

    ACCESSWIRE

    Moderna norovirus vaccine trial on hold by FDA

    REUTERS

    Moderna Reports Q4 and Fiscal Year 2024 Financial Results

    ACCESSWIRE

    Moderna takes $238M contract manufacturing cancellation charge

    FIERCE PHARMA

    Moderna Lays Off Digital Team As CIO Departs

    FIERCE PHARMA

    Moderna picks Merck KGaA, Roivant alum as marketing chief

    FIERCE PHARMA

    Moderna to Report Q4 & Full Year 2024 Financial Results Feb 14

    ACCESSWIRE

    Moderna, Novo slammed for breaching UK drug marketing code again

    FIERCE PHARMA

    Moderna Awarded Tender for Supply of COVID-19 Vaccine in the Europe

    ACCESSWIRE

    Moderna Announces Updates on Pandemic Influenza Program

    ACCESSWIRE

    Moderna cuts 2025 sales forecast by $1 B on weak vaccine demand

    REUTERS

    Moderna Provides Business Updates at 43rd J.P. Morgan Conference

    ACCESSWIRE

    Etherna lands $950M biobucks deal with Kenneth Chien`s Dropshot

    FIERCE BIOTECH

    Moderna CEO confronts challenges for RSV, COVID businesses

    FIERCE PHARMA

    Personalis Advances Strategy with Merck Investment, Moderna Deal

    BUSINESSWIRE

    Moderna’s RSV Vaccines Run Into Safety Roadblock

    BIOSPACE

    Moderna to Present at Upcoming Conferences in December 2024

    ACCESSWIRE

    Canada approves Moderna`s RSV vaccine for adults aged 60 & older

    REUTERS

    Moderna surprise profit on higher-than-expected COVID vaccine sales

    REUTERS

    Carisma`s Moderna-powered cell therapy shrinks tumors in mice

    FIERCE BIOTECH

    Moderna to Present at Upcoming Conferences in November 2024

    ACCESSWIRE

    Merck, Moderna Launch Phase 3 Trial for NSCLC Treatment

    BUSINESSWIRE

    Moderna mounts campaign to boost vaccine eligibility awareness

    FIERCE PHARMA

    Moderna Named a Top Employer by Science for Tenth Consecutive Year

    ACCESSWIRE

    UK’s first norovirus mRNA vaccine trial launched

    PHARMABIZ

    Moderna to Report Q3 2024 Financial Results on Nov. 7, 2024

    ACCESSWIRE

    GSK sues Moderna for US patent infringement over COVID, RSV vaccines

    REUTERS

    Novavax Receives EU Authorization For Updated COVID Vaccine

    REUTERS

    Alnylam drops patent lawsuit against Moderna over Covid-19 vaccine

    ENDPTS

    Abbas Hussain Joins Moderna`s Board of Directors

    ACCESSWIRE

    Moderna Doses First Participant In Ph 3 Norovirus Vaccine Trial

    ACCESSWIRE

    Moderna, Cenra Healthcare joins To Promote mRNA Vaccines

    ACCESSWIRE

    Moderna rebuked over second successive Spikevax marketing breach

    FIERCE PHARMA

    Moderna blamed after kids sent $2,000 COVID vaccine trial offer

    FIERCE PHARMA

    Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK

    REUTERS

    Moderna Gets Health Canada Approval For COVID-19 Vaccine Targeting KP.2 Variant

    ACCESSWIRE

    Moderna Cuts R&D Spending, Focuses on Oncology

    CONTRACTPHARMA

    Moderna forecasts lower sales next year, shares near four-year low

    REUTERS

    Carisma And Moderna Expand In Vivo Cell Therapy To Autoimmune Diseases

    FIERCE BIOTECH

    Carisma And Moderna Expand CAR-M Therapy Collaboration

    PR NEWSWIRE

    Moderna`s Canadian Facility Gets Health Canada License

    ACCESSWIRE

    Moderna`s Mpox Vaccine Shows Better Outcomes in Monkeys Than Bavarian Nordic

    FIERCE BIOTECH

    Taiwan FDA Approves Moderna’s COVID-19 mRNA Vaccine For JN.1 Variant

    ACCESSWIRE

    EU approves Moderna`s RSV vaccine for over 60s

    ECONOMICTIMES

    Japan Approves Moderna`s COVID-19 mRNA Vaccine For SARS-COV-2 Variant JN.1

    ACCESSWIRE

    Pfizer-BioNTech COVID-19 Vaccine Gets FDA Approval & Authorization

    BUSINESSWIRE

    Moderna Therapeutics`s mResvia Receives Approval in Europe

    EMA

    US FDA approves updated COVID shots ahead of fall and winter

    REUTERS

    Omega Therapeutics Names Jennifer Nelson As Senior VP Of Research

    GLOBENEWSWIRE

    Moderna unveils free Coursera curriculum on mRNA medicines to boost STEM skills

    FIERCE PHARMA

    Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026

    REUTERS

    Moderna Reports Q2 2024 Results And Provides Business Updates

    ACCESSWIRE

    Leveragen And Moderna Collaborate On Antibody Technology

    BUSINESSWIRE

    CDC Recommendations Reduce Long-Term US RSV Market Value: Airfinity

    FIERCE PHARMA

    RSV vaccine makers vying for market share in second year of shots

    REUTERS

    Should Merck Buy Out Moderna on Keytruda–Cancer Vaccine Partnership?

    BIOSPACE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.